Spero Therapeutics, Inc. Stock Issued During Period, Shares, Conversion of Units
Spero Therapeutics, Inc. (SPRO) reported Stock Issued During Period, Shares, Conversion of Units of 1 shares for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-10.
Discontinued › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits · last filed 2023-08-10
- 2023-06-30: Stock Issued During Period, Shares, Conversion of Units 6 month 1.00 shares.
| Period end | Stock Issued During Period, Shares, Conversion of Units 6 month |
|---|---|
| 2023-06-30 | 1.00 shares 10-Q · filed 2023-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 |